Pfizer to Seek U.S. Authorization For COVID-19 Booster Shot
Pfizer Inc plans to ask U.S. regulators to authorize a booster dose of its COVID-19 vaccine within the next month, based on evidence of greater risk of reinfection six months after inoculation and the spread of the highly contagious Delta variant. Awesome!
Photo Credit: Martin Sanchez
15 views0 comments